Real-time enrollment status for this end stage liver disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT03228290 |
| Recruiting Status | Recruiting |
| Condition | End Stage Liver Disease |
| Phase | Clinical Trial |
| Target Enrollment | 5,000 participants |
| Active Locations | 12 sites in the US |
| Sponsor | University of California, San Francisco |
| Last Updated on CT.gov | July 4, 2025 (Jul 4, 2025) |
As of July 13, 2026: Clinical trial NCT03228290 is currently recruiting participants. This clinical trial study for end stage liver disease is actively seeking new participants at 12 locations across the United States. The study is sponsored by University of California, San Francisco. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03228290 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03228290 was last updated Jul 4, 2025 (July 4, 2025). HelloStudys verifies this status automatically.